Fortitude Family Office, LLC Neurocrine Biosciences Inc Transaction History
Fortitude Family Office, LLC
- $253 Billion
- Q3 2024
A detailed history of Fortitude Family Office, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fortitude Family Office, LLC holds 17 shares of NBIX stock, worth $2,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 9
88.89%
Holding current value
$2,370
Previous $1.24 Million
58.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.39 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$718 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$359 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$260 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...